Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: MPLT

MapLight Therapeutics, Inc.

Healthcare | Biotechnology

No licensed closing price on file for MPLT. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

MapLight Therapeutics, Inc. (NASDAQ: MPLT) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-19 20:32 UTC.

Key facts

Charts

Charts are in the appInteractive charts for MPLT are available in Oxford Ledge.
Open MPLT in Oxford Ledge →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-10-16
  • 2026-10-16Chief Scientific OfficerSale-11,513$93.0K
  • 2026-10-16Chief Executive OfficerSale-73,691$595.4K
  • 2026-10-16CAO and Interim CFOSale-10,167$82.1K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →
For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for MPLT and 5,000+ tickers.

Create a free account — keep MPLT
For your agent
GET /api/data?ticker=MPLT

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt